论文信息 - TRIZAL study: switching from successful HAART to TrizivirTM (abacavir‐lamivudine‐zidovudine combination tablet): 48 weeks efficacy, safety and adherence results - 字舞流文

TRIZAL study: switching from successful HAART to TrizivirTM (abacavir‐lamivudine‐zidovudine combination tablet): 48 weeks efficacy, safety and adherence results

B. Gazzard | C. Katlama | A. Lazzarin | J. Mallolas | N. Clumeck | A. Lafeuillade | S. Fenske | J. Mamet | L. Beauvais | Lauriane Beauvais